Real-World Bleeding Outcomes Among Hospitalized Patients Receiving Apixaban or Rivaroxaban: A Single-Center Retrospective Cohort Study.

O'Rear C, Chapa-Rodriguez A, Singh A, Afzal S, Acharya R, Wickham M, Younus U

Open source

DOI
10.3390/ph19091345
Published
2026 Aug 26
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19091345,
  title = {Real-World Bleeding Outcomes Among Hospitalized Patients Receiving Apixaban or Rivaroxaban: A Single-Center Retrospective Cohort Study.},
  author = {O'Rear C and Chapa-Rodriguez A and Singh A and Afzal S and Acharya R and Wickham M and Younus U},
  year = {2026},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph19091345},
  url = {https://doi.org/10.3390/ph19091345}
}

RIS

TY  - JOUR
TI  - Real-World Bleeding Outcomes Among Hospitalized Patients Receiving Apixaban or Rivaroxaban: A Single-Center Retrospective Cohort Study.
AU  - O'Rear C
AU  - Chapa-Rodriguez A
AU  - Singh A
AU  - Afzal S
AU  - Acharya R
AU  - Wickham M
AU  - Younus U
PY  - 2026
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph19091345
UR  - https://doi.org/10.3390/ph19091345
ER  - 

APA

C, O., A, C., A, S., S, A., R, A., M, W., & U, Y. (2026). Real-World Bleeding Outcomes Among Hospitalized Patients Receiving Apixaban or Rivaroxaban: A Single-Center Retrospective Cohort Study.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19091345

Source records